Streetbeat News

Products Services

BCDA

BioCardia has received CMS approval for coverage of its CardiAMP Cell Therapy Phase III study in heart failure, potentially accelerating patient enrollment and advancing the therapy's development.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 11:04 am

TSLA

Canaccord Genuity analyst George Gianarikas views Tesla Inc (TSLA) as a solid buy, setting a price target of over $230. He attributes the current stock slump to poor earnings revisions but is optimistic about Tesla's growth in vehicle prices, next-gen vehicles, FSD adoption, and energy storage. Despite aggressive price cuts to boost sales, Tesla's strategy pressures rivals and maintains competitiveness, especially in the US, Europe, and China.

Portfolio Pulse from Anan Ashraf

March 12, 2024 | 10:45 am

KALV

KalVista Pharmaceuticals has received the Promising Innovative Medicine Designation from the UK Medicines and Healthcare Products Regulatory Agency for Sebetralstat, a treatment for Hereditary Angioedema.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 10:38 am

MNOV

MediciNova announced new data and results for MN-166 (Ibudilast) in treating chlorine gas-induced acute lung injury at the Society of Toxicology's annual meeting. This development could signal progress in their research and potential for future applications.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 10:36 am

BTCUSD

ETHUSD

Former President Donald Trump has shifted his stance on cryptocurrencies from skepticism in 2019 to actively engaging and promoting them in 2024, including selling a collection of sneakers for Bitcoin and trading Ethereum. His meme cryptocurrency, MAGA (TRUMP), has seen a significant return. This change reflects a broader acceptance of cryptocurrencies, as evidenced by Bitcoin's recent surge to new all-time highs.

Portfolio Pulse from Benzinga Neuro

March 12, 2024 | 10:35 am

REVB

Revelation Biosciences announced positive data on its proprietary formulation, Gemini, showing its potential in improving kidney function and reducing inflammation related to acute kidney injury. Gemini, a phosphorylated hexaacyl disaccharide (PHAD), is under development for various applications including the prevention of hospital-acquired infections and treatment of acute and chronic organ diseases.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 10:24 am

VLVLY

Volvo Cars (OTC:VLVLY) has partnered with Breathe Battery Technologies to reduce EV charging times by up to 30%. The collaboration aims to enhance charging efficiency using Breathe's battery management software, which promises faster charging while maintaining battery health. This move is part of Volvo's broader strategy to transition to electric mobility, including adopting Tesla's North American charging standard and phasing out diesel cars by 2024.

Portfolio Pulse from Benzinga Neuro

March 12, 2024 | 10:22 am

IDYA

MRK

Ideaya Biosciences has partnered with Merck to conduct a Phase 1 trial evaluating IDEE161 in combination with Keytruda for endometrial cancer. This collaboration includes a clinical trial collaboration and supply agreement.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 10:11 am

TSLA

Tesla Inc (NASDAQ:TSLA) has announced an offer for long-term shareholders to receive early delivery of the Foundation Series Cybertruck. Eligibility requires a reservation in the participant's name before March 1, 2024, and proof of owning Tesla shares on specific dates with a minimum of 500 shares by Feb. 29, 2024. The offer aims to reward loyal shareholders amidst high demand and production challenges, with Tesla aiming to deliver 250,000 Cybertrucks in North America by 2025.

Portfolio Pulse from Anan Ashraf

March 12, 2024 | 10:00 am

ABNB

Airbnb, Inc. (NASDAQ:ABNB) announced a global ban on indoor security cameras in listings to prioritize customer privacy. The updated policy also includes stricter guidelines for outdoor cameras and devices like noise monitors, while allowing doorbell cameras and noise decibel monitors. The policy change, effective April 30, aims to provide clearer rules for the Airbnb community. The company has seen a 40% share price increase over the past year and reported strong financial results for the fourth quarter, including $63 million in net cash from operating activities. Airbnb also initiated a $6 billion share repurchase program and forecasts first-quarter revenue between $2.03 billion and $2.07 billion, with expectations of a higher take rate and moderate nights booked growth.

Portfolio Pulse from Nabaparna Bhattacharya

March 12, 2024 | 9:47 am